Arcadia Biosciences logo

Arcadia BiosciencesNASDAQ: RKDA

Profile

Country:

United States

IPO:

15 May 2015

Next earnings report:

28 February 2025

Last dividends:

N/A

Next dividends:

N/A
$3.62 M
-93%vs. 3y high
8%vs. sector
-vs. 3y high
-vs. sector
-81%vs. 3y high
17%vs. sector
-92%vs. 3y high
39%vs. sector

Price

regular market | Wed, 20 Nov 2024 21:00:00 GMT
$2.65-$0.18(-6.51%)

Dividend

No data over the past 3 years
$1.54 M$1.15 M
$1.54 M-$1.61 M

Analysts recommendations

Institutional Ownership

RKDA Latest News

Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y
zacks.com18 November 2024 Sentiment: POSITIVE

RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.

Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
zacks.com12 November 2024 Sentiment: NEUTRAL

Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.

Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript
seekingalpha.com12 November 2024 Sentiment: NEUTRAL

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2024 Financial Results and Business Highlights Conference Call.

Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
zacks.com14 August 2024 Sentiment: POSITIVE

Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.

Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
zacks.com13 August 2024 Sentiment: NEGATIVE

Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.

Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration
businesswire.com30 July 2024 Sentiment: NEGATIVE

LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.

Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call
businesswire.com30 July 2024 Sentiment: POSITIVE

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can joi.

Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
zacks.com17 July 2024 Sentiment: POSITIVE

Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
zacks.com17 May 2024 Sentiment: POSITIVE

Arcadia Biosciences (RKDA) is using the sale of its GoodWheat brand to expand its wheat intellectual property.

Arcadia Biosciences (RKDA) To Host Investor Call To Discuss Recent Transactions
businesswire.com17 May 2024 Sentiment: POSITIVE

Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will be hosting a call for analysts and investors on May 22, 2024, after the market closes. The conference call, scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time), will focus on recent strategic transactions. Interested participants can join the call through an audio-only webcast.

  • 1(current)

What type of business is Arcadia Biosciences?

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

What sector is Arcadia Biosciences in?

Arcadia Biosciences is in the Consumer Defensive sector

What industry is Arcadia Biosciences in?

Arcadia Biosciences is in the Packaged Foods industry

What country is Arcadia Biosciences from?

Arcadia Biosciences is headquartered in United States

When did Arcadia Biosciences go public?

Arcadia Biosciences initial public offering (IPO) was on 15 May 2015

What is Arcadia Biosciences website?

https://www.arcadiabio.com

Is Arcadia Biosciences in the S&P 500?

No, Arcadia Biosciences is not included in the S&P 500 index

Is Arcadia Biosciences in the NASDAQ 100?

No, Arcadia Biosciences is not included in the NASDAQ 100 index

Is Arcadia Biosciences in the Dow Jones?

No, Arcadia Biosciences is not included in the Dow Jones index

When was Arcadia Biosciences the previous earnings report?

No data

When does Arcadia Biosciences earnings report?

The next expected earnings date for Arcadia Biosciences is 28 February 2025